A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

This study is ongoing, but not recruiting participants.

Study NCT00912288 Information provided by Pfizer

First Received: June 1, 2009 Last Updated: August 17, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2011
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)